Ascentage Pharma Group International

HKEX:6855.HK

41.05 (HKD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Operating Activities:
Net Income 163.001-523.286-402.351-476.19-406.734-405.742-376.682-358.429-319.177-847.399-633.315-228.424-116.883-86.327-86.327-29.629-29.629-29.629-26.96-26.96-26.96
Depreciation & Amortization 47.31247.61945.57629.87231.04413.00514.52112.75613.73313.35712.4369.7488.3994.6164.6163.1253.1253.1250.3870.3870.387
Deferred Income Tax 000-10.622037.86800000-30.361-13.66300000000
Stock Based Compensation 8.7313.25418.24916.5285.57720.0326.94140.60933.41868.1792.64327.5756.8946.8946.89400016.24816.24816.248
Change In Working Capital 0-69.0120104.3730-74.9110-55.25103.457024.892-10.1446.776.772.6332.6332.6330.5370.5370.537
Accounts Receivables 0-91.5370-0.3880-53.968000000000000000
Change In Inventory 0-6.7190-5.5180-3.93000000000000000
Change In Accounts Payables 000000000000000000000
Other Working Capital 029.2440110.2790-17.0130-55.25103.457024.892-10.14400000000
Other Non Cash Items -573.434173.812-29.9386.70334.912196.514-18.35548.977-26.592519.288401.04945.5191.6518.6318.631-3.126-3.126-3.126-1.685-1.685-1.685
Operating Cash Flow -354.391-357.613-368.464-318.714-335.201-251.104-353.575-311.338-298.618-243.118-217.187-120.69-116.977-59.417-59.417-26.996-26.996-26.996-11.473-11.473-11.473
Investing Activities:
Investments In Property Plant And Equipment -16.526-12.133-33.975-91.845-111.443-222.173-213.242-120.726-129.195-60.406-17.05-9.122-5.135-12.365-12.365-5.134-5.134-5.134-0.843-0.843-0.843
Acquisitions Net 0-200-200-200000029.979-33.37800000000
Purchases Of Investments 00000000000-486.531000000000
Sales Maturities Of Investments 00000000000456.552000000000
Other Investing Activites -114.752118.829-30.799-130.166-31.158780.123-791.23220.311-77.757-103.619-20.25856.256284.18712.36512.3655.1345.1345.1340.8430.8430.843
Investing Cash Flow -131.27886.696-64.774-242.011-142.601537.95-1,004.47299.585-206.952-164.025-37.30847.134245.674-12.365-12.365-5.134-5.134-5.134-0.843-0.843-0.843
Financing Activities:
Debt Repayment -98.852029.6350467.1920123.7380197.069061.093048.37200000000
Common Stock Issued 00000000000108.0700.0040.004000000
Common Stock Repurchased -1.959-12.3050-26.7760-25.874000000-75.59200000000
Dividends Paid 000000000000-77.21600000000
Other Financing Activities 497.717-74.578425.999198.287-19.435730.856952.667846.622-3.688385.3-4.031792.43694.94712.496-32.552-29.5750-29.57570.794070.794
Financing Cash Flow 396.906-86.883455.634171.511447.757704.9821,076.405846.622193.381385.357.062792.43667.727-32.552-32.552-29.575-29.575-29.57570.79470.79470.794
Other Information:
Effect Of Forex Changes On Cash 3.1495.85721.95644.18413.828-21.591-1.688-43.6331.946-0.0691.24320.7976.1665.2885.288-8.222-8.222-8.2220.7540.7540.754
Net Change In Cash 952.434-351.94344.352-345.03-16.217970.237-283.33591.236-310.243-21.912-196.19-32.665213.706235.567235.567-69.927-69.927-69.92759.23259.23259.232
Cash At End Of Period 952.4341,038.0481,389.9911,345.6391,690.6691,706.886736.6491,019.979428.743738.986760.898184.747217.411239.272239.2723.7053.7053.70573.63273.63273.632